The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Anzupgo LEO Pharma Pty Ltd
Product name
Anzupgo
Sponsor
Accepted date
Jan-2025
Active ingredients
delgocitinib
Proposed indication
ANZUPGO (Delgocitinib) is indicated for the treatment of chronic hand eczema in adults.
Application type
A (new medicine)
Publication date
Jan-2025